FDA Inspection
Amphastar Nanjing Pharmaceuticals IncAmphastar Nanjing Pharmaceuticals Inc – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Amphastar Nanjing Pharmaceuticals Inc, with an inspection on April 28, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 4fc6bd5e-2e76-4169-ba5f-13b6dada7297
Inspection Facts
- Inspection number
- 1017547
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Amphastar Nanjing Pharmaceuticals Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 19, 2025 | Not classified | Office of Inspections and Investigations | |
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| October 11, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Amphastar Nanjing Pharmaceuticals Inc
- FDA Inspection 1291882 - 2025-09-19
- FDA Inspection 1269036 - 2025-03-07
- FDA Inspection 1107981 - 2019-10-11
- FDA Inspection 1036696 - 2017-10-26
- FDA Inspection 969870 - 2016-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.